Carlsmed names Richard Heppenstall CFO, succeeding Leo Greenstein

By Public Technologies
  • Carlsmed appointed Richard Heppenstall as chief financial officer, effective immediately.
  • Heppenstall replaces Leo Greenstein, who is leaving to pursue other professional interests.
  • Heppenstall was CFO and treasurer at ZimVie from 2021 until its acquisition in October 2025.
  • Earlier roles include CFO at Breg and senior finance leadership at Orthofix Medical, Solera Holdings, Flowserve, and CooperVision.
  • Full-year 2026 revenue guidance reaffirmed at $74 million to $78 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280830PRIMZONEFULLFEED9834946) on September 28, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.